MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
- Conditions
- Breast Cancer
- Interventions
- Procedure: magnetic resonance imagingProcedure: radiomammographyProcedure: ultrasound imaging
- Registration Number
- NCT00874458
- Lead Sponsor
- Centre Antoine Lacassagne
- Brief Summary
RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread.
PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women with ductal carcinoma in situ.
- Detailed Description
OBJECTIVES:
Primary
* Assess the contribution of MRI in accurately determining tumor size in women with ductal breast carcinoma in situ (DCIS).
Secondary
* Evaluate the sensitivity of MRI in detecting DCIS.
* Evaluate the contribution of mammography in accurately determining tumor size.
* Compare the contribution of MRI vs mammography in assessing tumor extension.
* Compare the contribution of MRI vs mammography in assessing dense breasts.
* Evaluate the morphology of DCIS by MRI.
* Evaluate the curve of dynamic MRI in assessing DCIS.
* Evaluate the impact of nuclear grade of DCIS by MRI.
* Evaluate the rate of revision surgery.
OUTLINE: Patients undergo clinical examination, mammography, ultrasound imaging, unilateral breast MRI, and tissue sampling.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MRI ultrasound imaging - MRI magnetic resonance imaging - MRI radiomammography -
- Primary Outcome Measures
Name Time Method Correlation of tumor extension by MRI with surgical histology up to 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Antoine Lacassagne
🇫🇷Nice, France